Defending champion Carlos Alcaraz, who has won the French Open twice, now faces a cloud of doubt over his ability to compete at Roland Garros because of a troublesome right‑wrist problem. The Spanish prodigy, currently ranked world No. 2, has been forced to sit out recent events and is awaiting a series of medical examinations that will decide whether he can step onto the Parisian clay in a month. Alcaraz spoke to the press after being honored as Sportsman of the Year at the Laureus awards on Monday.
When asked about his fitness, the seven‑time Grand Slam winner gave a measured response: “We’ll see,” he said, acknowledging that the next medical assessment would be pivotal. The 22‑year‑old, who withdrew from the Madrid Open earlier this week, explained to Spanish broadcaster TVE that his team is "doing everything we can to make sure that this test goes well" and that he is trying to remain patient while awaiting the results. "We have a few tests in the next few days and then we will see how the injury is, and what the next steps will be," Alcaraz added. The player’s last competitive appearance was at the Barcelona Open, where he pulled out after treating his wrist during a straight‑sets win (6‑4, 6‑2) over Finland’s Otto Virtanen.
That withdrawal came just a day after he first sought medical attention for the sore joint. In the meantime, Alcaraz is focusing on a positive mindset.
"For now, I’ve been trying to stay positive, to stay upbeat, even though these days have become a bit too long," he told reporters. The young Spaniard’s optimism reflects his determination to return to form, but the reality of a wrist injury for a player whose game relies heavily on powerful forehands and precise timing cannot be ignored.
The wrist is a critical asset for any modern tennis player, especially one who generates as much topspin and speed as Alcaraz. A lingering injury could affect his ability to hit his signature aggressive groundstrokes, serve with his usual velocity, and execute the quick reflexes required at the net.
Medical experts typically evaluate such injuries through a combination of MRI scans, ultrasound imaging, and functional tests that assess strength, flexibility, and pain thresholds. The outcome of these examinations will dictate whether Alcaraz can safely compete without risking further damage. If the tests reveal only a minor strain, Alcariz could be cleared to play, perhaps with a modified training schedule and a protective brace.
However, a more serious diagnosis—such as a ligament tear or chronic inflammation—might necessitate a longer rehabilitation period, potentially forcing him to miss the French Open altogether. Missing Roland Garros would be a significant blow not only to Alcaraz’s personal ambitions but also to the tournament’s narrative, as fans anticipate a showdown between the young Spaniard and other top contenders like Novak Djokovic and Rafael Nadal, who are also seeking to add another title to their legacies.
The broader tennis community is watching closely. The ATP and WTA tours have already highlighted Alcaraz’s situation in their news feeds, and broadcasters such as Sky Sports are preparing contingency plans for coverage should the champion be forced to withdraw. Meanwhile, fans can follow the unfolding story through live updates, video highlights, and analysis on platforms like the Sky Sports app, which offers extensive coverage of both men's and women's tours.
In a parallel story of triumph, Belarusian star Aryna Sabalenka was also in the spotlight at the Laureus ceremony. She confessed to feeling "goosebumps" as she joined an elite roll of honour that includes legends such as Jennifer Capriati, Justine Henin, Serena Williams, Naomi Osaka, Simone Biles, Shelly‑Ann Fraser‑Pryce, Annika Sörenstam, and Lindsey Vonn. Sabalenka, the world No.
1 in women’s tennis, described the moment as both "crazy" and "emotional," noting that being listed alongside athletes she has long admired was a humbling experience. The awards ceremony in Madrid, hosted by tennis icon Novak Djokovic and freestyle‑skiing sensation Eileen Gu, celebrated achievements across a wide spectrum of sports. While Sabalenka’s accolade highlighted the growing prominence of women in athletics, Alcaraz’s predicament underscored the physical vulnerabilities that even the most gifted athletes can face.
Looking ahead, the next few days will be crucial for Alcaraz. His medical team will likely conduct a series of diagnostic scans, followed by a detailed assessment of his wrist’s range of motion and strength. Depending on the findings, they may recommend a tailored rehabilitation program that could include physiotherapy, low‑impact conditioning, and gradual re‑introduction to on‑court practice.
The goal will be to restore full functionality while minimizing the risk of re‑injury, especially with the French Open looming. Should Alcaraz be cleared to play, he will have roughly four weeks to fine‑tune his game on clay, a surface that demands endurance, strategic point construction, and the ability to slide efficiently—attributes that could be compromised if his wrist remains sore. Conversely, a withdrawal would open the draw to other hopefuls, potentially reshaping the tournament’s dynamics and providing an unexpected opportunity for emerging talents.
Regardless of the outcome, Alcaraz’s situation serves as a reminder of the thin line between peak performance and physical setbacks in elite sport. Fans, commentators, and fellow players alike will be watching the forthcoming medical reports with keen interest, hoping for a swift and positive resolution that allows the young champion to defend his title and continue his meteoric rise in the tennis world.